海创药业(688302)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688302 海创药业

交易中 12-20 10:21:17

{"stockData":{"symbol":"688302","market":"SH","secType":"STK","nameCN":"海创药业","latestPrice":32.4,"timestamp":1734661277000,"preClose":32.38,"halted":0,"volume":191586,"delay":0,"floatShares":72724500,"shares":99015600,"eps":-2.1228,"marketStatus":"交易中","marketStatusCode":2,"change":0.02,"latestTime":"12-20 10:21:17","open":32.58,"high":32.85,"low":32.27,"amount":6237200,"amplitude":0.0179,"askPrice":32.5,"askSize":3,"bidPrice":32.4,"bidSize":52,"shortable":0,"etf":0,"ttmEps":-2.1228,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1734665400000},"adr":0,"adjPreClose":32.38,"symbolType":"stock_kcb","openAndCloseTimeList":[[1734658200000,1734665400000],[1734670800000,1734678000000]],"highLimit":35.62,"lowLimit":29.14,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":99015598,"pbRate":2.6,"roa":"--","roe":"--","epsLYR":-2.97,"committee":0.630252,"marketValue":3208000000,"floatMarketCap":2356000000,"peRate":-15.26286,"changeRate":0.0006,"turnoverRate":0.0026,"status":0},"requestUrl":"/m/hq/s/688302","defaultTab":"news","newsList":[{"id":"2492117559","title":"海创药业-U12月19日遭主力抛售138万元 环比增加1050.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492117559","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492117559?lang=zh_cn&edition=full","pubTime":"2024-12-19 15:20","pubTimestamp":1734592801,"startTime":"0","endTime":"0","summary":"12月19日, 海创药业-U股价涨0.15%，报收32.38元，成交金额1192万元，换手率0.51%，振幅2.72%，量比0.55。海创药业-U今日主力资金净流出138万元，上一交易日主力净流出12万元，今日环比增加1050.00%。该股近5个交易日下跌9.33%，主力资金累计净流出641万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出2798万元，其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219160503ab83e5ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219160503ab83e5ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688302"],"gpt_icon":0},{"id":"2489993420","title":"海创药业遭第二大股东再度减持 上市以来亏损超7亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489993420","media":"新京报","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489993420?lang=zh_cn&edition=full","pubTime":"2024-12-06 12:39","pubTimestamp":1733459950,"startTime":"0","endTime":"0","summary":"作为海创药业的第二大股东，盈创动力所持海创药业股份自2023年6月15日解除限售并上市流通以来，已累计减持1998453股。2024年前三季度，海创药业实现营收10.97万元，亏损1.54亿元。上市不足三年的时间，海创药业已经累计亏损超7亿元。2023年11月29日，海创药业发布公告，再度提交的氘恩扎鲁胺软胶囊新药上市申请被国家药监局药品审评中心受理。截至目前，海创药业的氘恩扎鲁胺软胶囊尚无更新进展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206124530ab619e76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206124530ab619e76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688302"],"gpt_icon":0},{"id":"2489461192","title":"海创药业-U创新低 券商建议增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2489461192","media":"智选洞察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489461192?lang=zh_cn&edition=full","pubTime":"2024-12-05 09:30","pubTimestamp":1733362206,"startTime":"0","endTime":"0","summary":"12月05日，海创药业-U股价大幅下跌，截至09点30分，海创药业-U下跌5.36%，报33.03元/股，创近1个月新低，成交115万元，换手率0.05%，振幅2.49%。资金动向截止发稿，海创药业-U获得主力净流出47万元。融资融券方面，海创药业-U12月03日获得融资净买入99万元，当日该股融资余额为5139万元，当较前一日增加1.97%。最新财报显示，今年三季报，海创药业-U实现营业收入10.97万元，同比减少-%，净利润为-1.54亿元，同比增长35.28%，基本每股收益为-1.56元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120509305898e5774f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120509305898e5774f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688302","BK0239"],"gpt_icon":0},{"id":"2489253464","title":"海创药业股东盈创动力拟减持不超过297万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2489253464","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489253464?lang=zh_cn&edition=full","pubTime":"2024-12-05 09:09","pubTimestamp":1733360985,"startTime":"0","endTime":"0","summary":"公告显示，截至2024年12月5日，公司的大股东成都盈创动力创业投资有限公司持有公司股份857万股，占公司总股本的8.6552%。因自身资金需求，盈创动力计划自公告披露之日起十五个交易日后的三个月内，通过集中竞价和大宗交易方式减持公司股份，合计不超过297万股，占公司总股本的3%。盈创动力在过去12个月内已减持156万股，占公司总股本的1.5804%。文章来源：财中社海创药业股东盈创动力拟减持不超过297万股","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205091910a1d4f1e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205091910a1d4f1e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688302","BK0239"],"gpt_icon":0},{"id":"2488511885","title":"公司热点｜频遭二股东减持！多年营收为零 海创药业还要亏损到何时？","url":"https://stock-news.laohu8.com/highlight/detail?id=2488511885","media":"读创财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488511885?lang=zh_cn&edition=full","pubTime":"2024-12-04 22:45","pubTimestamp":1733323509,"startTime":"0","endTime":"0","summary":"二股东多次减持截至公告披露日，盈创动力持有公司股份856.9996万股，占公司总股本8.6552%，为公司第二大股东。自2023年底以来，盈创动力已先后四次减持海创药业股份。多年营收为零二股东用脚投票下，海创药业多年营收为零且持续亏损。2024年前三季度，公司实现营收11万元，归母净利润亏损1.54亿元。这对急需营收的海创药业来说可谓雪上加霜。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204230006a26c6d11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204230006a26c6d11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688302"],"gpt_icon":0},{"id":"2488819616","title":"海创药业：股东盈创动力拟减持不超过3%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2488819616","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488819616?lang=zh_cn&edition=full","pubTime":"2024-12-04 21:30","pubTimestamp":1733319019,"startTime":"0","endTime":"0","summary":"海创药业公告称，公司持股5%以上的股东成都盈创动力创业投资有限公司（简称“盈创动力”）计划自本公告披露之日起十五个交易日后的三个月内，通过集中竞价交易方式和大宗交易方式减持公司股份合计不超过297.05万股，减持比例不超过公司总股本的3%。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120400039619.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688302","BK0239"],"gpt_icon":0},{"id":"2488196587","title":"海创药业：第二大股东盈创动力拟减持不超3%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2488196587","media":"界面","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488196587?lang=zh_cn&edition=full","pubTime":"2024-12-04 21:25","pubTimestamp":1733318730,"startTime":"0","endTime":"0","summary":"海创药业12月4日公告，因自身资金需求，第二大股东成都盈创动力创业投资有限公司（以下简称“盈创动力”）计划自公告披露之日起十五个交易日后的三个月内，通过集中竞价交易方式、大宗交易方式减持公司股份合计不超过297.0465万股，合计减持比例不超过公司总股本的3%。其中，通过集中竞价交易方式减持不超过99.0155万股，即不超过公司总股本的1%；通过大宗交易方式减持不超过198.031万股，即不超过公司总股本的2%。截至公告披露日，盈创动力持有公司股份856.9996万股，占公司总股本8.6552%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204212531abf5a60b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204212531abf5a60b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688302"],"gpt_icon":0},{"id":"2488919581","title":"海创药业(688302.SH)：盈创动力拟减持不超3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2488919581","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488919581?lang=zh_cn&edition=full","pubTime":"2024-12-04 21:16","pubTimestamp":1733318187,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海创药业(688302.SH)发布公告，成都盈创动力创业投资有限公司(简称“盈创动力”)计划自本公告披露之日起十五个交易日后的三个月内，通过集中竞价交易方式、大宗交易方式减持公司股份合计不超过297.05万股，合计减持比例不超过公司总股本的3%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1220534.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688302"],"gpt_icon":0},{"id":"2488133966","title":"【机构调研记录】诺安基金调研牧原股份、海创药业等11只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2488133966","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488133966?lang=zh_cn&edition=full","pubTime":"2024-12-02 08:03","pubTimestamp":1733097783,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及11月29日披露的机构调研信息，诺安基金近期对11家上市公司进行了调研，相关名单如下：1）牧原股份 个股亮点：公司是我国境内最大的自育自繁自养一体化的生猪养殖企业之一；牧原转债于2021-09-10上市；公司与元素驱动合作成立了河南牧元安粮公司，年产3万吨合成生物项目已开工。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120200001057.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0187","BK0028","BK0195","688302","BK0197","BK0056","BK0239","BK0240","BK0070","002714","BK0196"],"gpt_icon":0},{"id":"2488561337","title":"【机构调研记录】安信基金调研海创药业、华测检测等4只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2488561337","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488561337?lang=zh_cn&edition=full","pubTime":"2024-12-02 08:02","pubTimestamp":1733097735,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及11月29日披露的机构调研信息，安信基金近期对4家上市公司进行了调研，相关名单如下：1）海创药业 个股亮点：公司是一家基于氘代技术和PROTAC靶向蛋白降解等技术平台，专注于肿瘤、代谢性疾病等重大治疗领域的创新药物研发。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120200001007.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688302","LU1820825898.SGD","300012","BK0239","BK0159","BK0221","LU1146622755.USD","BK0132","LU2460026573.USD"],"gpt_icon":0},{"id":"2488613374","title":"【机构调研记录】嘉实基金调研歌力思、海创药业等14只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2488613374","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488613374?lang=zh_cn&edition=full","pubTime":"2024-12-02 08:02","pubTimestamp":1733097726,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及11月29日披露的机构调研信息，嘉实基金近期对14家上市公司进行了调研，相关名单如下：1）歌力思 个股亮点：公司线上销售的主营业务收入占比为10.15%；公司在2022年4月22日发布300个NFT收藏藏品；公司百秋网络运营模式包括网红带货2）海创药业 个股亮点：公司是一家基于氘代技术和PROTAC靶向蛋白降解等技术平台，专注于肿瘤、代谢性疾病等重大治疗领域的创新药物研发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120200000999.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0070","603808","688302","BK0239","BK0253"],"gpt_icon":0},{"id":"2488618093","title":"【机构调研记录】兴业基金调研海创药业、福光股份等7只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2488618093","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488618093?lang=zh_cn&edition=full","pubTime":"2024-12-02 08:01","pubTimestamp":1733097690,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及11月29日披露的机构调研信息，兴业基金近期对7家上市公司进行了调研，相关名单如下：1）海创药业 个股亮点：公司是一家基于氘代技术和PROTAC靶向蛋白降解等技术平台，专注于肿瘤、代谢性疾病等重大治疗领域的创新药物研发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120200000968.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688010","688302","BK0225","BK0239"],"gpt_icon":0},{"id":"2486499336","title":"海创药业-U 涨5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486499336","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486499336?lang=zh_cn&edition=full","pubTime":"2024-11-28 09:31","pubTimestamp":1732757477,"startTime":"0","endTime":"0","summary":"11月28日，海创药业-U股价大幅上涨，截至09点31分，海创药业-U上涨5.44%，报37.38元/股，成交410万元，换手率0.16%，振幅4.51%。资金动向截止发稿，海创药业-U获得主力净流入68万元，其中超大单流出49万元，大单流入117万元。最新财报显示，今年三季报，海创药业-U实现营业收入10.97万元，同比减少-%，净利润为-1.54亿元，同比增长35.28%，基本每股收益为-1.56元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128093539abe4894b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128093539abe4894b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688302"],"gpt_icon":0},{"id":"2486094485","title":"海创药业-U 氘恩新药推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2486094485","media":"智选洞察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486094485?lang=zh_cn&edition=full","pubTime":"2024-11-26 09:46","pubTimestamp":1732585574,"startTime":"0","endTime":"0","summary":"11月26日，海创药业-U股价大幅上涨，截至09点46分，海创药业-U上涨5.22%，报36.31元/股，成交848万元，换手率0.33%，振幅5.62%。消息解读海创药业近日在投资者互动平台上透露，其氘恩扎鲁胺软胶囊的新药上市申请审评程序正在有序推进中，并将根据项目进展及时向公众披露相关信息。资金动向截止发稿，海创药业-U获得主力净流入77万元，其中超大单流入54万元，大单流入23万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126094639abdf36b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126094639abdf36b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688302"],"gpt_icon":0},{"id":"2485233991","title":"海创药业：公司氘恩扎鲁胺软胶囊(项目号：HC-1119)新药上市申请审评程序正在正常进行中","url":"https://stock-news.laohu8.com/highlight/detail?id=2485233991","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485233991?lang=zh_cn&edition=full","pubTime":"2024-11-22 15:52","pubTimestamp":1732261932,"startTime":"0","endTime":"0","summary":"每经AI快讯，有投资者在投资者互动平台提问：恭喜海床药业新药即将上市，有看到公司近期在积极拓展国内外商业渠道，考虑到氘代药潜在竞争对手的问题，公司有考虑引入石药集团国药、或者中国生物制药作为股东之一，以便借用其商业化渠道快速打开市场、做大做强吗？海创药业（688302.SH）11月22日在投资者互动平台表示，公司氘恩扎鲁胺软胶囊(项目号：HC-1119)新药上市申请审评程序正在正常进行中。公司将根据项目进展及时披露相关信息。同时，公司正在广泛寻求商业合作机会，积极拓展合作渠道。(记者 蔡鼎)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122155255abd6c7e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122155255abd6c7e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688302"],"gpt_icon":0},{"id":"2485287648","title":"海创药业-U11月22日遭主力抛售178万元 环比增加137.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485287648","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485287648?lang=zh_cn&edition=full","pubTime":"2024-11-22 15:20","pubTimestamp":1732260041,"startTime":"0","endTime":"0","summary":"11月22日, 海创药业-U股价跌5.40%，报收34.31元，成交金额3703万元，换手率1.45%，振幅5.62%，量比0.92。海创药业-U今日主力资金净流出178万元，连续4日净流出，上一交易日主力净流出75万元，今日环比增加137.33%。该股近5个交易日下跌5.90%，主力资金累计净流出659万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出2224万元，其中净流出天数为14日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122154017a24d4f7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122154017a24d4f7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688302"],"gpt_icon":0},{"id":"2485042285","title":"海创药业-U跌5% 2券商增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2485042285","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485042285?lang=zh_cn&edition=full","pubTime":"2024-11-22 14:17","pubTimestamp":1732256262,"startTime":"0","endTime":"0","summary":"11月22日，海创药业-U股价大幅下跌，截至14点17分，海创药业-U下跌5.02%，报34.45元/股，成交3093万元，换手率1.21%。资金动向截止发稿，海创药业-U获得主力净流出379万元，其中超大单流出98万元，大单流出279万元。融资融券方面，海创药业-U11月20日获得融资净买入363万元，当日该股融资余额为5065万元，当较前一日增加7.73%；该股融券余额为16万元，融券余量为0.48万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122141755a24d1fe9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122141755a24d1fe9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688302"],"gpt_icon":0},{"id":"2485430309","title":"海创药业-U11月21日遭主力抛售75万元 环比增加212.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485430309","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485430309?lang=zh_cn&edition=full","pubTime":"2024-11-21 15:20","pubTimestamp":1732173629,"startTime":"0","endTime":"0","summary":"11月21日, 海创药业-U股价跌0.96%，报收36.27元，成交金额3774万元，换手率1.42%，振幅4.59%，量比0.82。海创药业-U今日主力资金净流出75万元，连续3日净流出，上一交易日主力净流出24万元，今日环比增加212.50%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为50.00%，平均跌幅为2.68%。该股近5个交易日下跌4.35%，主力资金累计净流出699万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出1224万元，其中净流出天数为13日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121153348a24a9c90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121153348a24a9c90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688302"],"gpt_icon":0},{"id":"2484713381","title":"海创药业-U上涨 浦江论坛召开","url":"https://stock-news.laohu8.com/highlight/detail?id=2484713381","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484713381?lang=zh_cn&edition=full","pubTime":"2024-11-20 10:06","pubTimestamp":1732068399,"startTime":"0","endTime":"0","summary":"11月20日，海创药业-U股价大幅上涨，截至10点06分，海创药业-U上涨5.14%，报37.20元/股，成交1780万元，换手率0.68%。资金动向截止发稿，海创药业-U获得主力净流入70万元，其中超大单流入108万元，大单流出37万元。最新财报显示，今年三季报，海创药业-U实现营业收入10.97万元，同比减少-%，净利润为-1.54亿元，同比增长35.28%，基本每股收益为-1.56元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120100656a2473958&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120100656a2473958&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688302","BK0239"],"gpt_icon":0},{"id":"2484499169","title":"海创药业跌1.94% 2022年上市募资10.6亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484499169","media":"中国经济网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484499169?lang=zh_cn&edition=full","pubTime":"2024-11-19 16:16","pubTimestamp":1732004160,"startTime":"0","endTime":"0","summary":"　　海创药业首次公开发行股票募集资金总额为106,269.92万元，扣除发行费用后，募集资金净额为99,511.33万元。海创药业实际募资净额比原拟募资净额少150,884.55万元。海创药业于2022年4月7日披露的招股说明书显示，该公司拟募集资金250,395.88万元，分别用于研发生产基地建设项目、创新药研发项目、发展储备资金。　　海创药业首次公开发行股票的发行费用总额为6,758.59万元，其中，承销及保荐费5,037.19万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/jjxw/2024-11-19/doc-incwqvpn6089017.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2024-11-19/doc-incwqvpn6089017.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688302","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2022-04-12","address":"四川省成都市武侯区高新区科园南路5号蓉药大厦1栋4层附2、3号","stockEarnings":[{"period":"1week","weight":-0.0933},{"period":"1month","weight":-0.0848},{"period":"3month","weight":0.0665},{"period":"6month","weight":0.197},{"period":"1year","weight":-0.3626},{"period":"ytd","weight":-0.3781}],"companyName":"海创药业股份有限公司","boardCode":"AI0027","perCapita":"18383股","boardName":"医药制造业","registeredCapital":"9901万元","compareEarnings":[{"period":"1week","weight":-0.0264},{"period":"1month","weight":0.0072},{"period":"3month","weight":0.2314},{"period":"6month","weight":0.124},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1328}],"survey":"　　海创药业股份有限公司是一家基于氘代技术和PROTAC靶向蛋白降解等技术平台，以开发具有重大临床需求的Best-in-class（同类最佳）、First-in-class（国际首创）药物为目标的国际化创新药企业。公司的主要产品为肿瘤、代谢性疾病药品。公司在肿瘤和代谢性疾病领域重点布局，重点搭建了氘代药物研发平台、PROTAC靶向蛋白降解技术平台、靶向药物发现与验证平台与先导化合物优化筛选平台，形成了较强的研发优势和丰富的技术储备。","serverTime":1734661306829,"listedPrice":42.92,"stockholders":"3956人(较上一季度增加14.80%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海创药业(688302)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海创药业(688302)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海创药业,688302,海创药业股票,海创药业股票老虎,海创药业股票老虎国际,海创药业行情,海创药业股票行情,海创药业股价,海创药业股市,海创药业股票价格,海创药业股票交易,海创药业股票购买,海创药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海创药业(688302)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海创药业(688302)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}